GSK taps Viant to test blockchain-based tracking

Blockchain developers believe the tech is ideally suited to serve the biopharma industry's supply chain needs.

By Jennifer McKevitt • Jan. 3, 2018

Fujifilm invests in gene therapy startup

The Japanese photography company has turned its focus to drugmaking in recent years, as illustrated by its new equity stake in EdiGene Corp.

By Jacob Bell • Dec. 21, 2017

MilliporeSigma tapped by bluebird for manufacturing

For bluebird, the deal is another step toward solidifying a stronger production process for its gene therapies.

By Jacob Bell • Dec. 21, 2017

Regulatory reforms unstick CMO market in China

A pilot scheme introduced by the Chinese government has given domestic biopharma companies more flexibility to tap CMOs for their manufacturing needs.

By Wang Fangqing • Dec. 21, 2017

Juno inks CAR-T supply deal with Thermo Fisher

Manufacturing is a key hurdle for cell therapy, pushing developers to be proactive in setting up production and supply chain processes during clinical development.

By Ned Pagliarulo • Dec. 21, 2017

FDA plans tougher enforcement of homeopathic medicines

Under a proposed risk-based approach, the regulator would target products claiming to treat serious diseases or that contravene manufacturing standards.

By Suzanne Elvidge • Dec. 20, 2017

EMA signs off on Samsung BioLogics manufacturing plant

The Korean drugmaker claims Plant No. 2, as it's known, is the world's single largest biologics plant, with 150,000 liters of production capacity.

By Ned Pagliarulo • Dec. 14, 2017

Abzena tapped for preclinical ADC development

The CDMO has entered into an agreement worth more than $5 million with a U.S. biotech.

By Jacob Bell • Dec. 14, 2017

FDA warns Korean OTC manufacturer for GMP violations

A recent warning letter from the regulator flagged labeling concerns and lax quality control on the part of the Seoul-based drugmaker.

By Ned Pagliarulo • Dec. 14, 2017

Biocad set to begin selling biosimilars in North Africa

Through a partnership with the Moroccan firm Sothema Labs, the Russian biotech hopes to manufacture and market its copycat biologics in the region.

By Suzanne Elvidge • Dec. 14, 2017

PwC: Opioids and Medicare pressures will challenge industry in 2018

BioPharma Dive Senior Editor Lisa LaMotta sat down with the US Pharma and Life Science Leader from PwC to discuss issues to watch in 2018. 

By Lisa LaMotta • Dec. 12, 2017

How can healthcare supply chains improve? Experts weigh in.

From supplier relations to inventory management, healthcare is seen as one of the greatest opportunities for supply chain improvement. Here's why.

By Edwin Lopez • Dec. 11, 2017

Wuxi preps for biologics manufacturing surge in China

The contract manufacturer recently began operations at what it says is the world's largest production facility for biologics using single-use bioreactors. 

By Ned Pagliarulo • Dec. 7, 2017

FDA lays groundwork for regulating 3D-printed drugs

The agency says it's the first regulator in the world to provide technical guidelines for manufacturers seeking to make medical products on 3D printers. 

By Jacob Bell • Dec. 7, 2017

Meeting vessel fabrication challenges for Bio/Pharma applications

Proper installation and start-up of complex vessels for Bio/Pharma applications is critical to prevent installation damage and to ensure safe operation compliant with your company’s processing requirements.

Dec. 4, 2017

Cali to Massachusetts: We're the better biotech hub

The Golden State holds a number of advantages over its East Coast rival, including greater venture capital investments in life sciences, according to a new report.

By Jacob Bell • Dec. 1, 2017

Corning adds 185 jobs to support pharma packaging production

Stepped-up hiring is part of a major investment into Valor Glass, a damage-resistant type of glassware Corning developed together with Merck and Pfizer.

By Ned Pagliarulo • Nov. 30, 2017

Merck unveils big plans for new UK HQ

Dubbed UK Discovery Centre, the facility could support nearly 1,000 jobs, including 150 new research positions.

By Jacob Bell • Nov. 30, 2017

Fresenius builds out its US manufacturing presence

The German healthcare company plans to pump $100 million into an expansion of its North Carolina production site. 

By Suzanne Elvidge • Nov. 30, 2017

Bluebird Bio doubles down on viral manufacturing

The gene therapy biotech is adding to its manufacturing capabilities as it readies plans to bring multiple new products to market in the coming years. 

By Lisa LaMotta • Nov. 29, 2017

Modern medicine: Cell and gene therapy

Transporting time- and temperature-sensitive products is a challenging responsibility for companies who need a reliable partner to ensure these life-saving therapies are delivered efficiently and successfully.

Nov. 28, 2017

UPS digs deeper into drug distribution

The logistics provider obtained a license to relabel drugs for pharmaceutical manufacturing clients in Georgia.

By Edwin Lopez • Nov. 28, 2017

FDA releases its blistering Lupin warning letter

Lupin shares slumped when the drugmaker disclosed last week that it had been cited. Now published, the letter shows the extent of Lupin's violations. 

By Jacob Bell • Nov. 16, 2017

Recipharm to shutter two plants, cutting 225 jobs

The restructuring is part of Recipharm's efforts to boost the profitability of its solid dose manufacturing business. 

By Ned Pagliarulo • Nov. 16, 2017

Avista doubles API manufacturing capacity at CO facility

The CDMO has expanded in Massachusetts and North Carolina as well, aiming to build out the company's operational capacity.

By Ned Pagliarulo • Nov. 16, 2017